Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05898698 · ClinicalTrials.gov registry record
Prospective Case Registry for Wounds
A clinical trial of Wound Healing Delayed, sponsored by Kerecis.
- Active
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT05898698: Active study of Wound Healing Delayed, sponsored by Kerecis.
NCT05898698 is a study of Wound Healing Delayed that is active but no longer recruiting, run by Kerecis. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05898698, a study of Wound Healing Delayed, is active but no longer recruiting, sponsored by Kerecis.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a post-market, observational and non-interventional registry to collect real-world data in diverse clinical settings and wound applications of acellular fish skin graft (FSG). The registry will be multi-center , target a wide patient population and a variety of wounds to document the quality of wound care, patient outcomes, safety and long-term results.
Primary Outcome
Is time and frequency of complete wound closure by or on 32 weeks. Complete closure is referred to as full epithelialization with the absence of drainage.
Conditions Studied
Study Locations (1)
Virginia
- Kerecis - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-03-17 |
| Est. Completion | 2025-12-17 |
What the registry record for NCT05898698 still lists
NCT05898698 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Wound Healing Delayed appearing as the primary indexed condition, and to 0 interventions.
NCT05898698 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05898698 about?
NCT05898698 is a clinical study titled "Prospective Case Registry for Wounds". This is a post-market, observational and non-interventional registry to collect real-world data in diverse clinical settings and wound applications of acellular fish skin graft (FSG). The registry will be multi-center , target a wide patient population and a variety of wounds to document the quality...
What is the current status of trial NCT05898698?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2023-03-17. Estimated completion is 2025-12-17.
What conditions does trial NCT05898698 study?
This clinical trial studies the following conditions: Wound Healing Delayed.
Who is sponsoring clinical trial NCT05898698?
This trial is sponsored by Kerecis, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05898698 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI